Velocity Clinical Research-Providence is a clinical research site located in East Greenwich, Rhode Island, United States 02818.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Velocity Clinical Research-Providence has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Acute Treatment of Migraine, Attention Deficit/Hyperactivity Disorder, SARS-CoV-2 Infection, COVID-19.
Sponsors: Pfizer, Otsuka Pharmaceutical Development & Commercialization, Inc., BioNTech SE.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Velocity Clinical Research-Providence has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Velocity Clinical Research-Providence has 7 clinical trials on record, with 4 currently active. Their work covers Acute Treatment of Migraine, Attention Deficit/Hyperactivity Disorder, SARS-CoV-2 Infection, COVID-19.
Yes — Velocity Clinical Research-Providence holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.